BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 40 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $23,696,000 | +17.1% | 18,000,000 | -5.5% | 0.20% | -5.5% |
| Q1 2020 | $20,242,000 | -50.1% | 19,050,000 | -48.8% | 0.22% | -38.5% |
| Q4 2019 | $40,529,000 | +237.7% | 37,223,000 | +272.2% | 0.35% | +117.9% |
| Q2 2017 | $12,001,000 | +1867.4% | 10,000,000 | +1718.2% | 0.16% | +1057.1% |
| Q1 2014 | $610,000 | – | 550,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 5,950,000 | $6,146,000 | 4.56% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 37,943,000 | $39,192,000 | 0.73% |
| Sonora Investment Management, LLC | 4,670,000 | $4,791,000 | 0.50% |
| MIZUHO SECURITIES USA LLC | 5,900,000 | $6,096,000 | 0.36% |
| IRON Financial LLC | 430,000 | $446,000 | 0.33% |
| RWC Asset Management LLP | 7,300,000 | $7,528,000 | 0.32% |
| Calamos Advisors LLC | 49,525,000 | $51,243,000 | 0.28% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 5,777,000 | $5,977,000 | 0.24% |
| PALISADE CAPITAL MANAGEMENT, LP | 5,721,000 | $5,896,000 | 0.18% |
| Calamos Wealth Management LLC | 1,240,000 | $1,283,000 | 0.17% |